ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000261801.1	Methotrexate	Breast invasive carcinoma	0.032023793	Resistant
ENSG00000261801.1	Methotrexate	Pancreatic adenocarcinoma	0.016055535	Resistant